SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-000691
Filing Date
2024-05-09
Accepted
2024-05-09 16:01:50
Documents
59
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q atxs-20240331x10q.htm   iXBRL 10-Q 1074043
2 EX-31.1 atxs-20240331xex31d1.htm EX-31.1 12101
3 EX-31.2 atxs-20240331xex31d2.htm EX-31.2 11281
4 EX-32.1 atxs-20240331xex32d1.htm EX-32.1 7241
  Complete submission text file 0001410578-24-000691.txt   5054987

Data Files

Seq Description Document Type Size
5 EX-101.SCH atxs-20240331.xsd EX-101.SCH 34475
6 EX-101.CAL atxs-20240331_cal.xml EX-101.CAL 38077
7 EX-101.DEF atxs-20240331_def.xml EX-101.DEF 153498
8 EX-101.LAB atxs-20240331_lab.xml EX-101.LAB 343467
9 EX-101.PRE atxs-20240331_pre.xml EX-101.PRE 236265
63 EXTRACTED XBRL INSTANCE DOCUMENT atxs-20240331x10q_htm.xml XML 846294
Mailing Address 75 STATE STREET SUITE 1400 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 1400 BOSTON MA 02109 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37467 | Film No.: 24930307
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)